Advisory Committees

Acceleration Advisory Group

The Acceleration Advisory Group plays a key role in guiding and prioritizing the MLSC’s life sciences investments to accelerate the commercialization of life science technology and tech-bio convergence. Key areas include improving paths for regulatory and payor approval, de-risking the “valley of death” between grant funding and institutional funding for startups, and improving shared infrastructure in the Commonwealth to advance the convergence of cutting-edge technology (AI, automation, robotics, semiconductors, quantum, etc.) and life sciences.

Cures Advisory Group

The mission of the Cures Advisory Group is to provide strategic guidance and direction for the MLSC pertaining to advancing research in cures, with a focus on gene therapy and cell therapy. The advisory group plays a key role in guiding and prioritizing the MLSC’s life sciences investments and making recommendations to the MLSC President and CEO. Key areas would include CAR-T applications for Lupus, CRISPR for gene editing and regenerative medicine innovations, such as stem cell transplants. 

Discovery Advisory Group

The mission of the Discovery Advisory Group is to provide strategic guidance and direction to the MLSC on investments that support exploratory research, beta testing, and the development of novel approaches, with the goal of identifying and advancing groundbreaking opportunities across the life sciences. The advisory group plays a key role in guiding and prioritizing the MLSC’s life sciences investments and making recommendations to the MLSC President and CEO. These entrepreneurial effects focus on testing and refining concepts that could drive future innovation. 

Mental Health Advisory Group

The mission of the Mental Health Advisory Group is to provide strategic guidance and direction to the MLSC by helping guide and prioritize its life sciences investments and making recommendations on opportunities to advance mental health research. The Advisory Group will focus on expanding treatment options and strengthening the toolkit for care delivery, including emerging approaches such as psychedelics, transcranial magnetic stimulation, and virtual reality, as well as biomarker-based therapies and collaborative models of care.

Preventative/Personalized Medicine Advisory Group

The mission of the Preventative/Personalized Medicine Advisory Group is to provide strategic guidance and direction for the MLSC pertaining to advancing efforts in personalized medicine, centered on using biomarkers and microbiome data to design tailored treatments. The advisory group plays a key role in guiding and prioritizing the MLSC’s life sciences investments and making recommendations to the MLSC President and CEO. Focus areas would include gene and cell therapy, immunotherapy, and early intervention strategies for dementia.